“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...
Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...
Phlow will manufacture epinephrine API in Virginia while Fresenius Kabi formulates and fills finished doses in existing US ...
According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...
As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...
Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...
Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...